Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity

Journal of Lipid Research

Volumn 42, Issue 12, 2001, Pages 2007-2014

  Pascot, Agnès ^a,b   Lemieux, Isabelle ^a,b   Prud'homme, Denis ^c   Tremblay, Angelo ^c   Nadeau, André ^a   Couillard, Charles ^a   Bergeron, Jean ^a   Lamarche, Benoît ^a   Després, Jean Pierre ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Insulin; LDL particle size; Visceral obesity

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; BODY FAT; BODY MASS; CALCULATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DYSLIPIDEMIA; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; MORPHOMETRICS; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PARTICLE SIZE; PRIORITY JOURNAL; RISK FACTOR;

ABDOMEN; ADULT; AGED; ARTERIOSCLEROSIS; BLOOD GLUCOSE; BODY MASS INDEX; FASTING; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; HYPERLIPIDEMIAS; INSULIN; LIPIDS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; OBESITY; PARTICLE SIZE; RISK FACTORS;

EID: 0035667904     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. High density lipoprotein as a protective factor against coronary heart disease
2. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
3. The associations of high-density lipoprotein subclasses with insulin and glucose levels, physical activity, resting heart rate, and regional adiposity in men with coronary artery disease: The Stanford Coronary Risk Intervention Project baseline survey
4. Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses
5. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity
6. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study
7. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study
8. Isolated low HDL cholesterol: An insulin-resistant state only in the presence of fasting hypertriglyceridemia
9. Dyslipidaemia and obesity
10. Joint effects of triglyceride and LDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment
11. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (The PROCAM Experience)
12. Characterization of high density lipoprotein subspecies: Structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography
13. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol
14. Characterization of human high-density lipoproteins by gradient gel electrophoresis
15. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method
16. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease
17. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women
18. The distribution of high-density lipoprotein subfractions in coronary survivors
19. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients
20. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study
21. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease
22. Volume of the lung determined by helium dilution
23. The gross composition of the body
24. The Airlie (VA) consensus conference standardization of anthropometric measurements
25. Techniques for the measurement of visceral fat: A practical guide
26. Assessment of adipose tissue distribution by computed axial tomography in obese women: Association with body density and anthropometric measurements
27. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
28. Sur un dosage rapide du cholestérol lié aux beta-lipoprotéines du sérum
29. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
30. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
31. Increase in plasma high density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma
32. Zur bestimmung der plasmaglukosekonzentration mit der hexokinase-glucose-6-phosphatdehydrogenase-methode
33. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays
34. A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma
35. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
36. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study
37. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men
38. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?
39. Hyperalphalipoproteinemia: Characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity
40. Regional adiposity and morbidity
41. La différenciation sexuelle, facteur déterminant des formes de l'obésité
42. Abdominal obesity as important component of insulin-resistance syndrome
43. Visceral obesity in men: Associations with glucose tolerance, plasma insulin, and lipoprotein levels
44. Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol
45. Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia
46. The association of lipoprotein and hepatic lipase activities with high density lipoprotein subclass levels in men with myocardial infarction at a young age
47. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice
48. Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency
49. Human HDL cholesterol levels are determined by apoA-1 fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler